Stay updated on GLPG1690 in IPF: ISABELA2 Clinical Trial
Sign up to get notified when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.

Latest updates to the GLPG1690 in IPF: ISABELA2 Clinical Trial page
- Check4 days agoChange DetectedRevision note updated from v3.3.3 to v3.3.4 appears in the page revision section. This change does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page update adds new locations and removes existing ones for the ISABELA trial, updating the study sites list. This reflects revision v3.3.3.SummaryDifference1%

- Check54 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed, and updated the revision marker to v3.3.2. The deletions now describe PubMed publications as automatically created and reference revision v3.2.0.SummaryDifference0.0%

- Check61 days agoChange DetectedThe funding status notice about lapse in government funding and operating status updates has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedNo substantive content changes were observed; the updates seem limited to layout or UI adjustments, with the core study details and approvals unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check105 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference1%

Stay in the know with updates to GLPG1690 in IPF: ISABELA2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.